October 20, 2016

No Image

Today in Movie Culture: Tom Cruise Recreates His Best Roles, 'Thor: Ragnarok' Fan Trailer and More

Here are a bunch of little bites to satisfy your hunger for movie culture:

Career Re-creation of the Day:

Watch Tom Cruise reenact scenes from his most iconic movies, including Top Gun, A Few Good Men, Eyes Wide Shut and all five Mission: Impossible movies, with help from James Corden and Cuba Gooding Jr.:

[embedded content]

Actor in the Spotlight:

Speaking of the world’s biggest movie stars, Ranker compiled a supercut proving that Will Smith is always yelling:

[embedded content]

Fake Trailer of the Day:

The real trailer for Thor: Ragnarok will hopefully have a little more fun than this fan-made video, but it’s still a decent mashup (via Geek Tyrant):

[embedded content]

Cosplay of the Day:

When you just can’t find the right human friend to be the Garth to your Wayne from Wayne’s World cosplay, get yourself an Irish wolfhound (via Fashionably Geek):

Blooper Reel of the Day:

Watch an exhausting but hilarious nine-minute video of all of Kate McKinnon outtakes from the Ghostbusters remake (via /Film):

[embedded content]

Supercut of the Day:

For Fandor Keyframe, Philip Brubaker chronicles the history of movies featuring female presidents, including Independence Day: Resurgence:

[embedded content]

Genre Study of the Day:

See how the movies have depicted the future over the years in this chronological supercut of sci-fi movies (via One Perfect Shot):

[embedded content]

Vintage Image of the Day:

Danny Boyle, who turns 60 years old today, films a scene for Trainspotting with Ewan McGregor and Jonny Lee Miller:

Fan Theory of the Day:

The Film Theorists proposes that the Ouija movies, including the new prequel, area actually sequels to The Exorcist:

[embedded content]

Classic Trailer of the Day:

Today is the 10th anniversary of the theatrical release of Christopher Nolan’s The Prestige. Watch the original trailer for the movie below.

[embedded content]

and

Let’s block ads! (Why?)


No Image

Lawmakers Question Price Hikes For Leukemia Drug

Sen. Bernie Sanders, I-Vt., left, and Rep. Elijah Cummings, D-Md., are pictured in Washington last year. Sanders and Cummings are demanding information from a drug company that repeatedly has raised prices on a leukemia drug. Susan Walsh/AP hide caption

toggle caption

Susan Walsh/AP

Another pharmaceutical company is coming under fire for boosting the price of one of its drugs. Two lawmakers are demanding to know the justification for a more than $80,000 price hike for a year’s supply of a drug that treats leukemia patients.

As NPR’s Alison Kodjak reports:

“The drug is called Iclusig and it was approved in 2012 to treat a subset of patients with chronic myeloid leukemia.

“Sen. Bernie Sanders, I-Vt., and Rep. Elijah Cummings, D-Md., sent a letter to Ariad Pharmaceuticals asking it to explain the medication’s $200,000 price tag.

“The two lawmakers say the company boosted the price repeatedly and at the same time cut the dose, effectively raising the costs even more.

“In the letter, the lawmakers demanded details about the company’s profits and any programs it offers to cut patient costs.”

Sanders recently has taken up the fight against escalating drugs costs and Cummings is senior Democrat on the House Oversight and Government Reform Committee.

The Associated Press reports:

“According to data from Truven Health Analytics, the list price for a year’s supply of Iclusig tablets has increased from $114,960 in 2012 to $198,732 in October 2016.”

During that period, says the AP, the drug Iclusig was linked to life-threatening blood clots. Ariad took the drug off the market temporarily, then re-introduced it in late 2013 with added warnings and recommended it for a small subset of patients with chronic myeloid leukemia.

Ariad’s price hike was first reported earlier this month by The Street.

“Ariad says the price hikes are justified because Iclusig ‘addresses an area of high unmet medical need in an ultra-orphan patient population of around 1,000-2,000 patients per year.’ “

As we have reported, Mylan Pharmaceuticals faced criticism this year over the price of EpiPen, which is used to treat allergic reactions, as did Turing Pharmaceuticals last year for the cost of Daraprim, which treats a deadly parasitic infection.

Let’s block ads! (Why?)


No Image

Watchdog: EPA Action To Protect Flint Residents From Lead Was Delayed 7 Months

A government watchdog’s report says Flint residents’ exposure to lead in city drinking water could have been stopped months earlier by federal regulators. Carlos Osorio/AP hide caption

toggle caption

Carlos Osorio/AP

The Environmental Protection Agency had the authority and information to issue an emergency order protecting residents of Flint, Mich., from lead-tainted water a full seven months before it did so, an EPA internal investigation has concluded.

“It is clear that EPA intervention was delayed,” the report from the EPA’s inspector general states. “These situations should generate a greater sense of urgency.”

By June 2015, the EPA regional office “had information that the city of Flint exceeded the lead level at which corrosion control is required, and that Flint was not using a corrosion inhibitor.” It also knew that testing showed high levels of lead in at least four homes. Finally, the regional office “knew that the state and local authorities were not acting quickly to protect human health.”

That is enough to issue an emergency order, the report says. Such action “could have required the city and state to provide alternative water supplies to affected residents, study the extent and severity of lead contamination within the water system, or immediately begin corrective actions to reduce and eliminate lead contamination in the drinking water system.”

And yet, the EPA did not issue an order until January 2016. According to the report, local authorities “believed that the state of Michigan’s actions to address the Flint situation barred formal federal action.” But that was incorrect – the Safe Drinking Water Act states that the EPA can take action if “state actions are deemed insufficient.”

The watchdog’s report concludes that the agency “needs to clarify for its employees how its emergency authority can and should be used to intervene in a public health threat.”

The EPA is among the people and groups under fire for the slow response to Flint’s lead-laced water. An independent task force concluded earlier this year that a state environmental agency called the Michigan Department of Environmental Quality bears primary responsibility, though others are also to blame.

The problem began when Flint switched to a new water source in 2014 for cost reasons. But water from that new source, the Flint River, was not adequately treated with corrosion controls and caused lead from the city’s pipes to leach into the drinking water supply. And as we’ve reported, the city switched back to its original water supply late last year, but it was too late to reverse the damage to the pipes.

The city is in the process of treating its water system and recent test results show that lead levels have improved.

High levels of lead are especially dangerous for children and can cause “learning disabilities, behavioral problems and mental retardation,” the World Health Organization said.

Catching up on the lead crisis in Flint? Our timeline takes you through how the public health disaster unfolded, step by step.

Let’s block ads! (Why?)